Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Osteoporosis Screening Is Underutilized Despite Recommendations

Mary Beth Nierengarten  |  Issue: August 2017  |  August 15, 2017

However, she emphasizes that older patients need to understand the importance of maintaining bone health, because of the cascading adverse events that occur once a fracture occurs.

What Can Rheumatologists Do to Improve Osteoporosis Screening?

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Educating patients about the need for maintaining bone strength into older age is one of the ways rheumatologists can help improve osteoporosis screening, according to Dr. Hansen, who is a coauthor on the updated 2017 ACR Guideline for the Prevention and Treatment of Glucocorticoid-Induced Osteoporosis.4 “We need to educate our patients that when you break a bone it will significantly influence not just your morbidity but your mortality,” she says. “We can protect the skeleton by prescribing osteoporosis medication.”

She emphasizes that rheumatologists need to advocate for their patients by ensuring bone density tests are properly reimbursed by insurance plans.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Dr. Gillespie also emphasizes the need for rheumatologists to discuss the importance of osteoporosis prevention, screening and management. “While common, osteoporosis and fragility fracture needn’t be an inevitable part of aging,” she says.


Mary Beth Nierengarten is a freelance medical journalist based in Minneapolis.

References

  1. U.S. Preventive Services Task Force. Screening for osteoporosis: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2011 Mar 1;154(5):356–364.
  2. Gillespie CW, Morin PE. Trends and disparities in osteoporosis screening among women in the United States, 2008–2014. Am J Med. 2017 Mar;130(3):306–316.
  3. Gillespie CW, Morin PE. Osteoporosis-related health services utilization following first hip fracture among a cohort of privately-insured women in the United States, 2008–2014: An observational study. J Bone Miner Res. 2017 May;32(5):1052–1061.
  4. Buckley L, Guyatt G, Fink HA, et al. 2017 American College of Rheumatology Guideline for the Prevention and Treatment of Glucocorticoid-Induced Osteoporosis. Arthritis Care Res (Hoboken). 2017 Aug;69(8):1095-1110.

Page: 1 2 3 | Single Page
Share: 

Filed under:ConditionsOsteoarthritis and Bone DisordersResearch Rheum Tagged with:bone density testbone diseasebone massbone mineral density (BMD)Fractureship fractureOsteoporosispreventionResearchrheumatologistscreeningWomen

Related Articles

    Unexpected Benefits of Bisphosphonates after Hip Fracture

    February 3, 2012

    Recent trials show this bisphosphonates can reduce subsequent hip fractures and mortality, while remaining cost effective.

    Build Up Bone

    June 1, 2007

    Current management of osteoporosis

    Osteoporosis Experts Discuss Bisphosphonate Holidays

    November 24, 2020

    ACR CONVERGENCE 2020—Bisphosphonates are an important treatment for millions of older Americans with osteoporosis because the drugs inhibit osteoclastic bone resorption to reduce the risk of painful, debilitating fractures.1 More than 20 years ago, data emerged that bisphosphonates have a long terminal half-life.2 So after years of therapy, could some patients take a drug holiday?…

    Prevent Osteoporotic Fractures with a Fracture Liaison Service

    May 18, 2019

    Imagine leaving the hospital after suffering a heart attack without being treated for hypertension or being started on a beta blocker. What would we think of the hospital where patients are never educated about the relationship between treating hypertension and reducing myocardial infarction and stroke risk? Unfortunately, this happens every day with osteoporosis and fractures…

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences